目前市值2.2亿,即使以2018年最高的0.22亿净利润计算,市盈率也达到了10,缺乏吸引力。查看全文
平凡Stone2021-02-03 23:06
$Kamada(KMDA)$ ARK fund Israel
Kamada Ltd.是一家通过销售市场现有罕见组合药物产品的,等离子体衍生蛋白质疗法公司。公司开发和生产的专业衍化蛋白质疗法产品,在一些新兴市场上,这些产品通过美洲和欧洲的战略合作伙伴被经营出售,或者通过当地的经销商直接在当地销售,该公司的旗舰产品是“...查看全文
一年交易一次2020-02-06 07:39
$Kamada(KMDA)$ Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2019, prior to the open of the U.S. financial markets on Wedne...查看全文
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-057156 Act: 34 Size: 28 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-056580 Act: 34 Size: 169 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-041491 Act: 34 Size: 899 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-040416 Act: 34 Size: 20 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-030392 Act: 34 Size: 42 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-025699 Act: 34 Size: 527 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-024615 Act: 34 Size: 20 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-020524 Act: 34 Size: 29 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-018909 Act: 34 Size: 32 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-014144 Act: 34 Size: 18 KB 网页链接